Home/Filings/4/0000899866-15-000124
4//SEC Filing

ALEXION PHARMACEUTICALS INC 4

Accession 0000899866-15-000124

CIK 0000899866operating

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:30 PM ET

Size

4.7 KB

Accession

0000899866-15-000124

Insider Transaction Report

Form 4
Period: 2015-05-20
Monnet Dominique
SVP, Chief Marketing Officer
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2015-05-20$162.40/sh256$41,5748,787 total
Footnotes (1)
  • [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000899866

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
4.7 KB